INTER K PTY LTD has a total of 25 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Australia, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MICROPHARM LTD, PHILOGEN SPA and SESEN BIO INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 9 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | United States | 3 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Enzymes | |
#5 | Analysing materials | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Agrez Michael Valentine | 22 |
#2 | Ahmed Nuzhat | 8 |
#3 | Dorahy Douglas | 3 |
#4 | Valentine Agrez Michael | 1 |
#5 | Agree Michael Valentine | 1 |
#6 | Agrez Michael Valentive | 1 |
#7 | Douglas Dorahy | 1 |
Publication | Filing date | Title |
---|---|---|
US2014187612A1 | Method of modulating integrin mediated cellular activity and agents useful for same | |
AU2010215086A1 | Inhibition of multiple cell activation pathways | |
EP2454276A1 | Therapeutic agents | |
US2011105408A1 | Therapeutic peptides | |
AU2007231835A1 | Screening assay for an inhibitor of MAP kinase?integrin binding | |
AU2005204275A1 | A method of modulating integrin mediated cellular activity and agents useful for same | |
WO2005037308A1 | Methods and agents for the treatment of cancer | |
AU2001297809B2 | MAP kinase integrin-binding domain | |
AU5510600A | A method of modulating integrin mediated cellular activity and agents useful for same |